Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens

被引:32
作者
Yan, Dan [1 ]
Weisshaar, Marco [1 ]
Lamb, Kristen [1 ]
Chung, Hokyung K. [2 ]
Lin, Michael Z. [3 ,4 ]
Plemper, Richard K. [1 ]
机构
[1] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA
[2] Stanford Univ, Dept Biol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
关键词
A VIRUS; NUCLEOTIDE ANALOG; DISEASE SEVERITY; CELL-ACTIVATION; UNITED-STATES; INFECTION; GENERATION; INHIBITORS; DYNAMICS; THERAPY;
D O I
10.1021/acs.biochem.5b00623
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myxoviruses such as influenza A virus (IAV) and respiratory syncytial virus (RSV) are major human pathogens, mandating the development of novel therapeutics. To establish a high-throughput screening protocol for the simultaneous identification of pathogen- and host-targeted hit candidates against either pathogen or both, we have attempted coinfection of cells with IAV and RSV. However, viral replication kinetics were incompatible, RSV signal window was low, and an IAV-driven minireplicon reporter assay used in initial screens narrowed the host cell range and restricted the assay to single-cycle infections. To overcome these limitations, we developed an RSV strain carrying firefly luciferase fused to an innovative universal small-molecule assisted shut-off domain, which boosted assay signal window, and a hyperactive fusion protein that synchronized IAV and RSV reporter expression kinetics and suppressed the identification of RSV entry inhibitors sensitive to a recently reported RSV pan-resistance mechanism. Combined with a replication-competent recombinant IAV strain harboring nanoluciferase, the assay performed well on a human respiratory cell line and supports multicycle infections. Miniaturized to 384-well format, the protocol was validated through screening of a set of the National Institutes of Health Clinical Collection (NCC) in quadruplicate. These test screens demonstrated favorable assay parameters and reproducibility. Application to a LOPAC library of bioactive compounds in a proof-of-concept campaign detected licensed antimyxovirus therapeutics, ribavirin and the neuraminidase inhibitor zanamivir, and identified two unexpected RSV-specific hit candidates, Fenretinide and the opioid receptor antagonist BNTX-7. Hits were evaluated in direct and orthogonal dos- response counterscreens using a standard recRSV reporter strain expressing Renilla luciferase.
引用
收藏
页码:5589 / 5604
页数:16
相关论文
共 87 条
  • [1] [Anonymous], CLIN EVID
  • [2] ARTEAGA CL, 1989, CANCER RES, V49, P4648
  • [3] Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain
    Beaudry, H.
    Gendron, L.
    Moron, J. A.
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2015, 41 (07) : 899 - 905
  • [4] Current and future antiviral therapy of severe seasonal and avian influenza
    Beigel, John
    Bray, Mike
    [J]. ANTIVIRAL RESEARCH, 2008, 78 (01) : 91 - 102
  • [5] New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions
    Beyleveld, Grant
    White, Kris M.
    Ayllon, Juan
    Shaw, Megan L.
    [J]. ANTIVIRAL RESEARCH, 2013, 100 (01) : 120 - 132
  • [6] Croup
    Bjornson, Candice L.
    Johnson, David W.
    [J]. LANCET, 2008, 371 (9609) : 329 - 339
  • [7] Analysis of cell-based RNAi screens
    Boutros, Michael
    Bras, Ligia P.
    Huber, Wolfgang
    [J]. GENOME BIOLOGY, 2006, 7 (07)
  • [8] Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
    Buchholz, UJ
    Finke, S
    Conzelmann, KK
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (01) : 251 - 259
  • [9] A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
    Cao, Jianzhong
    Forrest, J. Craig
    Zhang, Xuming
    [J]. ANTIVIRAL RESEARCH, 2015, 114 : 1 - 10
  • [10] Morphine Stimulates Cell Migration of Oral Epithelial Cells by Delta-Opioid Receptor Activation
    Charbaji, Nada
    Schaefer-Korting, Monika
    Kuechler, Sarah
    [J]. PLOS ONE, 2012, 7 (08):